220 related articles for article (PubMed ID: 23928726)
1. The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.
Di J; Duiveman-de Boer T; Zusterzeel PL; Figdor CG; Massuger LF; Torensma R
Cell Oncol (Dordr); 2013 Oct; 36(5):363-74. PubMed ID: 23928726
[TBL] [Abstract][Full Text] [Related]
2. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
Liu L; Wu L; Wei X; Ling J
Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
[TBL] [Abstract][Full Text] [Related]
3. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.
Wintzell M; Hjerpe E; Åvall Lundqvist E; Shoshan M
BMC Cancer; 2012 Aug; 12():359. PubMed ID: 22901285
[TBL] [Abstract][Full Text] [Related]
4. Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review.
van Schaijik B; Davis PF; Wickremesekera AC; Tan ST; Itinteang T
J Clin Pathol; 2018 Jan; 71(1):88-91. PubMed ID: 29180509
[TBL] [Abstract][Full Text] [Related]
5. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
[TBL] [Abstract][Full Text] [Related]
6. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Human Stem Cell Transcription Factors.
Sneha S; Nagare RP; Manasa P; Vasudevan S; Shabna A; Ganesan TS
Cell Reprogram; 2019 Aug; 21(4):171-180. PubMed ID: 31298562
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
9. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
10. Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer.
Virant-Klun I; Kenda-Suster N; Smrkolj S
J Ovarian Res; 2016 Mar; 9():12. PubMed ID: 26940129
[TBL] [Abstract][Full Text] [Related]
11. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.
Sotomayor P; Godoy A; Smith GJ; Huss WJ
Prostate; 2009 Mar; 69(4):401-10. PubMed ID: 19058139
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-independent fluctuation of pluripotency-related transcription factors and other epigenetic markers in embryonic stem cell colonies.
Sustáčková G; Legartová S; Kozubek S; Stixová L; Pacherník J; Bártová E
Stem Cells Dev; 2012 Mar; 21(5):710-20. PubMed ID: 21609209
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of NANOG and KLF4 for breast cancer.
Nagata T; Shimada Y; Sekine S; Hori R; Matsui K; Okumura T; Sawada S; Fukuoka J; Tsukada K
Breast Cancer; 2014 Jan; 21(1):96-101. PubMed ID: 22528804
[TBL] [Abstract][Full Text] [Related]
15. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
[TBL] [Abstract][Full Text] [Related]
16. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.
Heddleston JM; Li Z; McLendon RE; Hjelmeland AB; Rich JN
Cell Cycle; 2009 Oct; 8(20):3274-84. PubMed ID: 19770585
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
Rasti A; Mehrazma M; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Asgari M
Sci Rep; 2018 Aug; 8(1):11739. PubMed ID: 30082842
[TBL] [Abstract][Full Text] [Related]
19. Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.
Bindhya S; Sidhanth C; Krishnapriya S; Garg M; Ganesan TS
Int J Biochem Cell Biol; 2021 Sep; 138():106051. PubMed ID: 34343671
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
